Herb-drug interactions with anticancer agents. A surveillance programme by the clinical pharmacist.

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: VIQUEZ-JAIKEL, Alvaro (Caja Costarricense de Seguro Social, Pharmacy, San Jose, Costa Rica)
  • Co-author(s): Alvaro Viquez-Jaikel:
    Cristina Fernandez: Pharmacy, Caja Costarricense de Seguro Social, San Jose, Costa Rica
    Allan Ramos-Esquivel: Medical Oncology, Caja Costarricense de Seguro Social, San Jose, Costa Rica
  • Abstract:

    Methods

    Patients starting a new anticancer therapy were asked to fulfil a questionnaire to identify concomitant use of herb supplements. Two clinical pharmacists identified potential HDIs using two different databases. Each potential interaction was directly assessed by the clinical pharmacists to determine its reliability and clinical implications. 

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login